Monoclonal Antibodies: The Powerhouse of the Global Biologics Market
When analyzing the massive success of the modern pharmaceutical industry, all roads lead to monoclonal antibodies (mAbs). Currently acting as the undisputed heavyweight champion of the Biologics Market, mAbs account for over 55% of total industry revenue. By acting as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cancer cells or inflammatory proteins,...
0 Reacties 0 aandelen 437 Views 0 voorbeeld
SocioMint https://sociomint.com